Turgut, S. Et Al. 2017. The Role of p16 and MDM2 Gene Polymorphisms in Prolactinoma: MDM2 Gene Polymorphisms May Be Associated with Tumor Shrinkage. IN VIVO , vol.31, no.3 , 357-363.

Turgut, S., Ilhan, M., Turan, S., KARAMAN, Ö., Yaylim, I., Kucukhuseyin, O., ... TAŞAN, E.(2017). The Role of p16 and MDM2 Gene Polymorphisms in Prolactinoma: MDM2 Gene Polymorphisms May Be Associated with Tumor Shrinkage. IN VIVO , vol.31, no.3, 357-363.

Turgut, Seda Et Al. "The Role of p16 and MDM2 Gene Polymorphisms in Prolactinoma: MDM2 Gene Polymorphisms May Be Associated with Tumor Shrinkage," IN VIVO , vol.31, no.3, 357-363, 2017

Turgut, Seda Et Al. "The Role of p16 and MDM2 Gene Polymorphisms in Prolactinoma: MDM2 Gene Polymorphisms May Be Associated with Tumor Shrinkage." IN VIVO , vol.31, no.3, pp.357-363, 2017

Turgut, S. Et Al. (2017) . "The Role of p16 and MDM2 Gene Polymorphisms in Prolactinoma: MDM2 Gene Polymorphisms May Be Associated with Tumor Shrinkage." IN VIVO , vol.31, no.3, pp.357-363.

@article{article, author={Seda Turgut Et Al. }, title={The Role of p16 and MDM2 Gene Polymorphisms in Prolactinoma: MDM2 Gene Polymorphisms May Be Associated with Tumor Shrinkage}, journal={IN VIVO}, year=2017, pages={357-363} }